Abstract:Cognitive dysfunctions are core-enduring symptoms of schizophrenia, with important sex-related differences. Genetic variants of the DTBPN1 gene associated with reduced dysbindin-1 protein (Dys) expression negatively impact cognitive functions in schizophrenia through a functional epistatic interaction with Catechol-O-methyltransferase (COMT). Dys is involved in the trafficking of dopaminergic receptors, crucial for prefrontal cortex (PFC) signaling regulation. Moreover, dopamine signaling is modulated by estrogens via inhibition of COMT expression. We hypothesized a sex dimorphism in Dys-related cognitive functions dependent on COMT and estrogen levels. Our multidisciplinary approach combined behavioral-molecular findings on genetically modified mice, human postmortem Dys expression data, and in vivo fMRI during a working memory task performance. We found cognitive impairments in male mice related to genetic variants characterized by reduced Dys protein expression (p Bonferroni = 0.0001), as well as in male humans through a COMT/Dys functional epistatic interaction involving PFC brain activity during working memory (t(23) = −3.21; p FDR = 0.004). Dorsolateral PFC activity was associated with lower working memory performance in males only ( p = 0.04). Also, male humans showed decreased Dys expression in dorsolateral PFC during adulthood (p FDR = 0.05). Female Dys mice showed preserved cognitive performances with deficits only with a lack of estrogen tested in an ovariectomy model (p Bonferroni = 0.0001), suggesting that genetic variants reducing Dys protein expression could probably become functional in females when the protective effect of estrogens is attenuated, i.e., during menopause. Overall, our results show the differential impact of functional variants of the DTBPN1 gene interacting with COMT on cognitive functions across sexes in mice and humans, underlying the importance of considering sex as a target for patient stratification and precision medicine in schizophrenia.

Role of Dysbindin in Dopamine Receptor Trafficking and Cortical Gaba Function

Dysbindin Regulates Hippocampal Ltp by Controlling Nmda Receptor Surface Expression

The Pathogenic Mechanism of Dysbindin-1b Toxic Aggregation: Bloc-1 and Intercellular Vesicle Trafficking

Striatal dopamine release in a schizophrenia mouse model measured by electrochemical amperometry in vivo.

Schizophrenia Susceptibility Gene Dysbindin Regulates Glutamatergic and Dopaminergic Functions Via Distinctive Mechanisms in Drosophila

Dysbindin-1 Mutation Alters Prefrontal Cortex Extracellular Glutamate and Dopamine In Vivo

Loss of Dysbindin Implicates Synaptic Vesicle Replenishment Dysregulation as a Potential Pathogenic Mechanism in Schizophrenia

Dysbindin-1, BDNF, and GABAergic Transmission in Schizophrenia.

Dysbindin-1, BDNF, and GABAergic Transmission in Schizophrenia

Nucleocytoplasmic Shuttling of Dysbindin-1, a Schizophrenia-related Protein, Regulates Synapsin I Expression

Advances in the Studies of the Dysbindin Gene in Schizophrenia

DTNBP1, a Schizophrenia Susceptibility Gene, Affects Kinetics of Transmitter Release.

Increased Dysbindin-1B Isoform Expression in Schizophrenia and Its Propensity in Aggresome Formation

The Β-Alanyl-monoamine Synthase Ebony is Regulated by Schizophrenia Susceptibility Gene Dysbindin in Drosophila

The Schizophrenia-Related Protein Dysbindin-1a is Degraded and Facilitates Nf-Kappa B Activity in the Nucleus

Hippocampal Apoptosis and Cognitive Function in Dysbindin-1B+/+ Mice.

Protein Kinase B/Akt1 Phosphorylates Dysbindin-1A at Serine 10 to Regulate Neuronal Development

Dysbindin-1 regulates mitochondrial fission and gamma oscillations

Bdnf Rescues Prefrontal Dysfunction Elicited By Pyramidal Neuron-Specific Dtnbp1 Deletion In Vivo

A Dopamine D2 Receptor-Disc1 Protein Complex May Contribute to Antipsychotic-Like Effects.

Sex dimorphism controls dysbindin-related cognitive dysfunctions in mice and humans with the contribution of COMT